Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Molecular Cytogenetics is Scopus-indexed (Q2, CiteScore 3.3), WoS SCIE, DOAJ. Published by BioMed Central Ltd.
Checked against the index lists dated .
ISSN 1755-8166Verify ISSN ↗
Publisher: BioMed Central Ltd
Cost to publish: Checking DOAJ for article charges…
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Biochemistry (medical) | 37 / 78 | 53rd | Q2 |
| Genetics (clinical) | 61 / 100 | 39th | Q3 |
| Genetics | 232 / 357 | 35th | Q3 |
| Biochemistry | 307 / 448 | 31st | Q3 |
| Molecular Medicine | 133 / 179 | 25th | Q3 |
| Molecular Biology | 310 / 414 | 25th | Q3 |
Not listed in: ABDC, ABS / AJG, FT50, UT Dallas, ONOS (subscription), ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 2008–present, best quartile Q2, CiteScore 3.3.
Molecular Cytogenetics is Q2 in Biochemistry (medical) (rank 37 of 78), Q3 in Genetics (clinical) (rank 61 of 100) and Q3 in Genetics (rank 232 of 357), by CiteScore 2025. It is ranked in 6 subject areas in all.
Molecular Cytogenetics is indexed in the Science Citation Index Expanded, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. The closest free measure is its Scopus CiteScore 3.3, which places it in quartile Q2 at the 53rd percentile of its subject. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 0.485, quartile Q3, with an H-index of 42.
The publisher lists an article processing charge of about US$3,290 for open access (source: OpenAlex). Many journals also publish by the subscription route at no cost to the author, so confirm on the journal's own website.
Molecular Cytogenetics is published by BioMed Central Ltd. Its ISSN is 1755-8166.
Yes — indexed in the Science Citation Index Expanded.
Yes — it is an open-access journal, listed in DOAJ.
Molecular Cytogenetics has an h-index of 55 and a 2-year mean of 1.44 citations per paper (OpenAlex). Its Scopus CiteScore is 3.3, quartile Q2. On 2-year citations it ranks #39 of 77 Scopus journals in Biochemistry (medical).
Molecular Cytogenetics published 40 papers in 2025; its busiest recent year was 2018 with 63. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 99 research articles (2024–2026), authors are most often from China (38.4%), United States (11.4%) and France (4%).
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. No retracted papers are recorded. The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.